Posts by all

RadNet Participates in Exciting Clinical Trials to Evaluate and Stage Prostate Cancer

RadNet Participates in Exciting Clinical Trials to Evaluate and Stage Prostate Cancer

5/12/2021 | admin | 0 Comments | Category: Other Cancers

RadNet’s Research Division has been participating in two clinical trials of a prostate-specific Positron Emission Tomography (PET) tracer in men with newly diagnosed prostate cancer and those with a recurrence of prostate cancer after having undergone previous prostate cancer treatment. Under the guidance of Judith Rose M.D., Medical Director of PET/CT and Clinical Research for RadNet, and in conjunction with Dr. David Josephson M.D. of Tower Urology, and Blue Earth Diagnostics.

The Cancer Research Collaboration was honored to receive a donation from the Tarbut V' Torah Community Day School

6/27/2018 | Cancer Research Collaboration | 0 Comments | Category: Donations

The Cancer Research Collaboration was honored to receive a donation from the Tzedakah Board at Tarbut V' Torah Community Day School, made up of Bar and Bat Mitzvah students. Every year, instead of giving gifts to one another, they celebrate by pooling their money and donating it to charity, to make a difference in the world. This year, they raised over $3700.

Kia of Cerritos donates $10,000 to the Cancer Research Collaboration

Kia of Cerritos donates $10,000 to the Cancer Research Collaboration

12/21/2016 | Cancer Research Collaboration | 0 Comments | Category: Donations

On behalf of Kia of Cerritos, Deb McMahon and Teresa Kelly presented a check for $10,000 to Kristi Maya and Terri Herrick of the Cancer Research Collaboration. Deb and Teresa’s firm represent Kia of Cerritos and brought the two organizations together. Kia was excited to work with the Cancer Research Collaboration, knowing that they partnered with Breastlink to conduct trials, particularly breast cancer. Breast cancer is an important cause to the Kia owners and to show their support, they pledged 10 percent of each car they sold during Breast Cancer Awareness Month to the CRC.

Raven Quinn Donates Album Proceeds to the Cancer Research Collaboration

Album Proceeds to Benefit Cancer Research Collaboration

1/22/2016 | Cancer Research Collaboration | 0 Comments | Category: Donations

While news about an album release may seem surprising on a cancer research blog, the third album from Los Angeles-based singer-songwriter Raven Quinn is a little different. The Acoustic EP is the first album released by Raven Quinn since she was diagnosed with breast cancer in June 2015. Additionally, Raven will donate one-half of all proceeds from album sales to the Cancer Research Collaboration.

Palbociclib & Advanced ER-Positive Breast Cancer Treatment

Palbociclib & Advanced ER-Positive Breast Cancer Treatment

2/22/2015 | Cancer Research Collaboration | 0 Comments | Category: Breast Cancer

ibrance palbociclib er positive breast cancerWomen with advanced estrogen receptor-positive (ER-positive) breast cancer now have a new treatment option at their disposal. The FDA recently approved a drug called palbociclib (Ibrance®) as a frontline treatment for women with ER-positive, HER2-negative metastatic breast cancer.

Kadcyla Research Shows Promise in HER2 Positive Breast Cancer Treatment

Kadcyla Research Shows Promise in HER2 Positive Breast Cancer Treatment

7/28/2014 | Cancer Research Collaboration | 0 Comments | Category: Breast Cancer

Recent research into modern breast cancer therapies have driven major breakthroughs in antibody-drug conjugates, or “smart drugs,” which work by targeting cancer cells while minimizing damage to healthy body tissue.

Kadcyla, also known ado-trastuzumab emtansine (T-DM1), is one of the latest “smart drugs” 
to be FDA-approved in the treatment of women diagnosed with metastatic HER2-positive breast cancer. Kadcyla may also have potential as therapy after surgery where intent is curative.

RadNet Joins UCLA-Easton Center Alzheimer’s Disease Research Study

RadNet Joins UCLA-Easton Center Alzheimer’s Disease Research Study

7/8/2014 | Cancer Research Collaboration | 0 Comments | Category: Imaging, Other Cancers

RadNet Inc., a national leader in providing high-quality, cost-effective, fixed-site outpatient diagnostic imaging services through a network of 250 owned and/or operated outpatient imaging centers, announced it has joined a research study, the Imaging and Genetic Biomarkers for Alzheimer’s Disease (ImaGene) study.

The study is supported in part by GE Healthcare and sponsored by the Jim Easton Consortium for Alzheimer’s Disease Drug Discovery and Biomarkers, and, the National Institute of Aging.